STATESVILLE, N.C., Aug. 23 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its first quarter ended July 31, 2006 .

Sales for the quarter were $19,294,000 , a decrease of 5% from sales of $20,308,000 in the same period last year. Domestic sales of laboratory and technical furniture products declined 8%, while sales of the Company's Asian subsidiaries increased 22%. The order backlog at July 31, 2006 was $36.5 million , up slightly from $36.4 million at April 30, 2006 .

Net earnings for the quarter were $133,000 , or $0.05 per diluted share. Net earnings for the comparable period of the prior year, which benefited from an after-tax gain of $540,000 related to the sale of the Company's property in Texas, were $763,000 , or $0.31 per diluted share. Excluding the gain on the sale of the property, net earnings in the prior year period were $223,000 , or $0.09 per diluted share.

'The domestic market for laboratory and technical furniture products remains very competitive and price sensitive,' said William A. Shumaker, President and Chief Executive Officer. 'Pricing pressures, the continuing escalating costs of raw materials and energy, and higher borrowing costs continue to impact earnings. At the same time, however, our Asian subsidiaries continue to experience strong sales and earnings growth and have become a significant source of our revenue and earnings.

'Looking forward,' Mr. Shumaker continued, 'we remain committed to improving our profitability, both in the domestic and international markets. We are confident our plans for improving manufacturing efficiencies and reducing costs will allow us to successfully compete in the worldwide marketplace. We are continuing to aggressively expand our sales representation and capabilities in India and China to take advantage of the rapidly-growing Asian laboratory research market.'

The Company's balance sheet remained strong at the end of the quarter. Working capital was $11.0 million , including cash on hand of $2.1 million . Stockholders' equity was $25.5 million , or $10.22 per share. Total bank debt and capital lease obligations at July 31, 2006 were $9.4 million , resulting in a debt to equity ratio of .37-to-1.

The Company also announced today that its Board of Directors approved a cash dividend of seven cents per outstanding share to stockholders of record at the close of business on September 6, 2006 , payable on September 20, 2006 .

Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of scientific and technical furniture. The Company's corporate headquarters and manufacturing facilities are located in Statesville, North Carolina. The Company also has subsidiaries in Singapore and Bangalore , India that serve the Asian markets. Kewaunee Scientific's website is located at http://www.kewaunee.com.

Certain statements in this release constitute 'forward-looking' statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, services, and prices.



              Consolidated Statements of Operations [unaudited]
                    (in thousands, except per share data)

                                                           Three Months Ended
                                                          July 31     July 31
                                                             2006        2005

    Net sales                                             $19,294     $20,308
    Cost of products sold                                  16,166      16,922

    Gross profit                                            3,128       3,386
    Other operating income                                     --         884*
    Operating expenses                                      2,637       2,920

    Operating earnings                                        491       1,350
    Other income (expense)                                     18          (5)
    Interest expense                                         (187)        (87)

    Earnings before income taxes                              322       1,258
    Income tax expense                                         78         457

    Earnings before minority interests                        244         801
    Minority interests in subsidiaries                        111          38
    Net earnings                                             $133       $763*

    Net earnings per share
      Basic                                                 $0.05       $0.31
      Diluted                                               $0.05       $0.31

    Weighted average number of common shares
     outstanding (in thousands)
      Basic                                                 2,492       2,492
      Diluted                                               2,493       2,492

     * Includes a non-recurring pretax gain of $884,000 and an after-tax gain
       of $540,000, or $.22 per diluted share, on the sale of property.



                    Condensed Consolidated Balance Sheets
                                (in thousands)

                                                          July 31    April 30
                                                             2006        2006
    Assets                                             [unaudited]

    Cash and cash equivalents                              $2,087        $929
    Restricted cash                                           400         399
    Receivables, less allowances                           19,114      23,199
    Inventories                                             6,156       5,860
    Prepaid expenses and other current assets               1,298       1,011
      Total current assets                                 29,055      31,398
    Net property, plant and equipment                      11,129      11,163
    Other assets                                            8,012       7,911
    Total Assets                                          $48,196     $50,472

    Liabilities and Stockholders' Equity
    Short-term borrowings                                  $8,531      $8,216
    Current obligations under capital leases                  297         260
    Accounts payable                                        6,526       9,074
    Other current liabilities                               2,690       2,823
      Total current liabilities                            18,044      20,373
    Other non-current liabilities                           4,682       4,553
    Total stockholders' equity                             25,470      25,546
    Total Liabilities and Stockholders' Equity            $48,196     $50,472

     Contact:  D. Michael Parker
               704/871-3290

SOURCE Kewaunee Scientific Corporation